NPC has been shown to exhibit a type II infection latency, and the LMP1 gene is well_defined as an important oncogene of EBV and a poor prognostic biomarker in NPC patients [15,16]. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.